XTalks

APRIL 10, 2023

The publicly-listed startup has a number of patent applications, including one approved patent, on laboratory production processes that replicate the milk-producing cells of humans and other mammals. The process of creating a nutritious formula depends on the acquisition of human tissue cells.

Production 98

Production Marketing Containment Protein 98

Pharmaceutical Technology

MAY 5, 2023

Switzerland-based Siegfried has purchased a 95% stake in DiNAMIQS, a biotechnology firm that focuses on the development and production of viral vectors for cell and gene therapies. Siegfried will leverage DiNAMIQS’ capabilities to commercial scale by constructing a facility that complies with good manufacturing practice standards.

Gene Therapy 130

Gene Therapy Gene Development Production 130

Drug Discovery World

JUNE 13, 2023

Despite the therapeutic potential offered by CGTs, alongside the rapid growth of the sector (surpassing $90 billion by 2030, CAGR 22%), these advanced therapies remain largely unavailable to patients worldwide due to a disconnect between therapeutic innovation and manufacturing capability for affordable large-scale production. revolution.

Manufacturing 52

Manufacturing Gene Therapy Gene Production 52

Roots Analysis

AUGUST 29, 2023

Cell therapy consumables are materials which are used in the manufacturing of cell therapies, however, do not form a part of the final product. Raw materials used for the production of cell therapies include culture media, growth factors, extracellular matrices and reagents.

Reagent 52

Reagent Manufacturing Production Containment 52

pharmaphorum

SEPTEMBER 23, 2020

The theme of the event is ‘Exploring Agile Contamination Control Strategy’, where the two-day conference will be co-chaired by James Drinkwater, Head of Aseptic Processing Technologies & GMP Compliance, F Ziel GmbH and Jim Polarine, Senior Technical Service Manager, STERIS Corporation. Workshop A – 08.30 – 12.30 London, UK.

Contamination 52

Contamination Compliance Containment Regulation 52

The Pharma Data

OCTOBER 26, 2020

Under the terms of the agreement, Novasep will be in charge of developing and manufacturing (cell culture, AAV expression, purification, aseptic distribution and quality control) the two AAV vectors designed for the Sensorion OTOF-GT project and will supply Drug Product batches to support preclinical and clinical studies. Disclaimer.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

pharmaphorum

SEPTEMBER 28, 2022

This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and increased regulatory stringency, to the latest technologies in rapid microbiological testing methods and data integrity. Event Hashtag: #MicrobiologyEurope. Who Should Attend? Download the brochure at: [link].

Contamination 52

Contamination Compliance Production 52

pharmaphorum

MARCH 22, 2022

for manufacturing, with the aim of streamlining and enabling greater automation through adoption of digital tools, is leading to greater interest in the potential for VR and AR to improve efficiency and reduce costs in production. The pharma industry’s overall push into industry 4.0 The importance of manufacturing.

Manufacturing 137

Manufacturing Production Contamination Gene Therapy 137

Roots Analysis

JANUARY 14, 2024

Overview of Biologics Biologics refer to medicinal / therapeutic products that are either manufactured using living organisms or semi-synthesized from biological sources. Expression Systems for Biologics The processes associated with the manufacturing of biopharmaceuticals are complex and require highly sterile and aseptic conditions.

Contract Manufacturing 40

Contract Manufacturing Manufacturing Protein Bacteria 40

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. But what steps can the smaller companies at the cutting edge take to make them acquisition-ready and maximise their value during this process?

Compliance 119

Compliance Regulation Manufacturing Licensing 119

Roots Analysis

FEBRUARY 26, 2023

Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drug delivery strategies to the long-acting drug delivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.

Drug Delivery 52

Drug Delivery Drug Delivery Systems Drugs Marketing 52

Pharmaceutical Technology

FEBRUARY 3, 2023

When you consider the existing challenges limiting the upstream production of viral vectors, this figure becomes even more alarming. The established method for this process is a triple transfection using three different DNA plasmids. Naturally, scientists are investigating ways the transient transfection process could be improved.

Genome 244

Genome Genomics Medicine Gene Therapy 244

pharmaphorum

JULY 28, 2022

These supply chain issues raise significant risks for the industry due to shortcuts being taken that are not based on product safety and quality. Until the company is found to be in compliance, there will not be a normal distribution of drug products. Tackling shortages. The stakes are high. Logistical challenges.

Compliance 111

Compliance Drugs Manufacturing Generic Drugs 111

pharmaphorum

AUGUST 24, 2020

The conference is proudly chaired by Lynne Ensor, Vice President, Technical, Parexel International as a 21-year veteran of the FDA, her areas of expertise include biopharmaceutical sterile product manufacturing and testing, pharmaceutical microbiology, pharmacy compounding, and regulatory policy development. in Biology and Ph.D.

Contamination 52

Contamination In-Vitro Production Containment 52

Pharmaceutical Technology

DECEMBER 20, 2022

Modelling this newfound collaborative approach, a group of independent companies recently joined forces to combine and publish their data summarizing key progress and opportunities for industry-wide improvement in the area of aseptic filling. Working together to validate innovative fill-finish technology.

Regulation 130

Regulation Contamination Manufacturing Production 130

The Pharma Data

JANUARY 5, 2021

Lattice Biologics develops and manufactures biologic products to domestic and international markets. The Company’s products are used in a variety of surgical applications. Lattice Biologics maintains all necessary licensures to process and sell its tissue engineered products within the U.S. and internationally.

Engineer 40

Engineer Manufacturing Production Marketing 40

The Pharma Data

JUNE 7, 2022

based production in support of its COVID-19 oral treatment, PAXLOVID TM (nirmatrelvir [PF-07321332] tablets and ritonavir tablets). By increasing production at our Michigan facility, we are both helping patients around the world and expanding important manufacturing innovation to the U.S. manufacturing leadership.”.

Manufacturing 40

Manufacturing HR Production Vaccination 40

The Pharma Data

OCTOBER 22, 2021

Subject to reaching a final agreement, Novartis plans to transfer the manufacturing process from Stein to Ljubljana point to commence the filler and finish in the first half of 2022. Novartis products reach nearly 800 million people encyclopedically and we’re chancing innovative ways to expand access to our rearmost treatments.

Vaccination 52

Vaccination Vaccine Filler Contract Manufacturing 52

Pharmaceutical Technology

DECEMBER 13, 2022

Freeze drying, also known as lyophilisation, is a common method of preservation used in many products, from the fresh herbs and vegetables that top store-bought pizzas to the instant coffee in our morning brew. Many pharmaceutical products are sensitive to heat, therefore the ability to dry contents at low temperatures is a clear advantage.

Production 130

Production Contamination Manufacturing Packaging 130

pharmaphorum

NOVEMBER 24, 2022

Now, this service-centred model is delivering advantages in the pharmaceutical industry, with costly manufacturing facilities and processes becoming widely available on an on-demand basis. Different ISO standards are required depending on the processes and products developed within the environment. Meeting strict standards.

Manufacturing 98

Manufacturing Pharma Packaging Packaging Packaging 98

pharmaphorum

MARCH 8, 2022

Our products are used primarily in the fight against cancer – to aid drug discovery – while also ensuring patients and laboratory workers are safe. I’m constantly learning from his deep technical knowledge of the aseptic and healthcare processes. DI: It is very important, and we all need role models. A videh Nazeri.

Life Science 98

Life Science Engineer Scientist Doctors 98

Pharmaceutical Technology

NOVEMBER 22, 2022

Vaccines are our number one weapon in the fight against infectious diseases, but their development has historically involved a long and complex process taking up to a decade. When it comes to mRNA processing, dedicated consumables and equipment options suited to its characteristics are currently limited.

Manufacturing 130

Manufacturing Vaccination Vaccine RNA 130

Drug Discovery World

FEBRUARY 14, 2023

DDW Editor Reece Armstrong speaks to Peter Walters, Director Advanced Therapies, CRB, and Grace Linton , Director Process Architecture, CRB about automation within laboratory settings and its effect on the pharmaceutical industry. RA: How are labs utilising automated systems in regard to personalised medicines?

Gene Therapy 52

Gene Therapy Manufacturing Gene Medicine 52

Roots Analysis

SEPTEMBER 29, 2023

This simple technique streamlines downstream processes and preserves valuable resources. The sterile, closed systems protect the product and promote safe and reliable processing ( with certified container integrity ). Sample spike ports and sealed cryopreserved bags allow for safe transportation of aseptic items.

Contamination 40

Contamination Containment Biobanking Packaging 40

Drug Discovery World

OCTOBER 13, 2022

Despite the challenges involved in commercially manufacturing mRNA therapeutics successfully, CDMOs are investing in the capabilities to manufacture emerging mRNA product modalities to help stay ahead of pharma’s renewed mRNA development curve. . Why mRNA has potential . The rise of global demand . Expanding capabilities .

Drugs 52

Drugs Manufacturing Vaccination Vaccine 52

The Pharma Data

APRIL 27, 2021

Descemet’s Stripping Automated Endothelial Keratoplasty [DSAEK]); absent or ruptured posterior lens capsule, due to the risk of implant migration into the posterior segment; hypersensitivity to bimatoprost or to any other components of the product. NORTH CHICAGO, Ill.

Research 40

Research Drug Delivery Systems Drug Delivery Production 40

Pharmaceutical Technology

MARCH 23, 2023

When freeze drying sterile pharmaceuticals, mass spectrometry helps manufacturers protect valuable batches from silicone oil contamination – a possible risk of the lyophilisation process. As a heat transfer fluid, it is circulated through the metal bellows connected to the drying shelves, regulating the temperature during the drying process.

Contamination 130

Contamination Manufacturing Regulation Production 130

Pharmaceutical Technology

MARCH 22, 2023

During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. While production volumes have now fallen, future vaccine demand is hard to predict, as booster shots could be needed at any point to control emerging variants.

Contamination 130

Contamination Packaging Packaging Manufacturing 130